CAMBRIDGE (CBS) — Moderna says its vaccine is 96% effective in protecting kids between 12 and 17 years old against COVID-19. That data is from a study of more than 3,2000 participants who received at least one dose of the vaccine.
The Cambridge-based biotech company also said none of the participants had severe reactions to the first or to the second shot.READ MORE: Fourth Stimulus Check: Is Another Relief Payment Coming?
“No serious safety concerns have been identified to date,” Moderna said about the trial on teens.READ MORE: Child Tax Credit: September Payments Arriving In Parents' Bank Accounts
Moderna said another study of the vaccine on children 6 months to 11 years old is ongoing but didn’t give further details.MORE NEWS: Child Tax Credit: When Will Your September Payment Arrive?
Earlier this week Moderna, which is expanding its manufacturing plant and lab in Norwood, said a third vaccine booster dose it developed shows it works against the more contagious South African and Brazilian variants.